Acute pancreatitis promotes the expression of NO and inducible nitric oxide synthase (iNOS), which activates the NF-B signaling pathway, and mediates the increase induced by spinal cord cyclooxygenase-2 (COX-2) via IL-1, and stimulates pain in the body [101]
2023b;44(3):393416
Patients with uncontrolled hypertension, active infection, or certain cardiac conditions should consult providers before use
Once the solicitation opens on January 8, direct communication with the topic authors will no longer be allowed, so use this period wisely to refine your approach
Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
Handling & Storage Maintain under recommended laboratory conditions suitable for light and moisture sensitive materials
